Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by Ciaoon Jan 20, 2024 11:11am
87 Views
Post# 35837318

RE:RE:Gagnon's next pay check might be in trouble.

RE:RE:Gagnon's next pay check might be in trouble.
Alex1726 wrote: One thing is for sure , Gagnon doest not have the skills to manage AEZS it is defently to complicated for him , he can't even manage the sale of a natural product (aventramide) that has no competitor.

He was also not capable of managing a clinical study involving Oat beta glucan so how will he do to manage cliniclals studies in NMOSD AND PD.





We know he can't run AEZS, are you forgetting he was the CEO for AEZS for 10 years plus where during his leadership the share price dropped 90% or so. Once again he would be running the company in the comfort of his home in Sherbrooke on a part time basis.
<< Previous
Bullboard Posts
Next >>